The Zoomer Publication targets population of 15.1 million baby boomers in the Canadian market TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) is pleased to announce that the HeartCheck™ PEN ECG device and SMART Monitoring service were the subject of a special article in the October 2013 issue of Zoomer … Read more
North America plans will utilize social media strategies including calls to action for arrhythmia screening in sports TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has engaged The Lightning Group (“TLG”) and LOLA Social Marketing (“LOLA”) to provide on-line marketing and social media strategy services. In … Read more
Enhancements include symptom correlation to ECG readings TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirms it has released a new version of its GEMS Home software which is available to both new purchasers of the HeartCheckTM PEN ECG device as well as a free upgrade to current HeartCheckTM … Read more
TORONTO, ONTARIO – August 9, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 250,000 options to the Company’s CEO, Etienne Grima, in accordance with his employment agreement with the Company. The options … Read more
TORONTO, ONTARIO – August 2, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 377,129 common shares of the Company in settlement of services provided, as previously described in the Company’s press release … Read more
TORONTO, ONTARIO -July 12, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has agreed to issue 350,000 common shares of the Company at a deemed price of $0.15 per share as compensation for $52,500 worth of services … Read more
TORONTO, ONTARIO -May 21, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced that the Company has issued 29,201 shares to Mr. Simi Grosman, an independent member of the board of directors, for services rendered to the Company in the months of January, February and March of 2013. The shares were … Read more
The HeartCheck PEN ECG device is the first to utilize the patent pending SMART Monitoring technologies to enable/unlock a consumer medical devices to record, display, transmit and receive bio-signals and images. TORONTO, ONTARIO -May 9, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and … Read more
Leveraging national health care call centre infrastructure, North American HeartCheck PEN Consumers will have around the clock access to rapid physician ECG interpretations. TORONTO, ONTARIO – April 24, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today formally announced expansion … Read more
TORONTO, ONTARIO –April 19, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 750,000 stock options. 250,000 options were issued to the Company’s CEO, Etienne Grima, in accordance with his employment, and 500,000 … Read more